| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
activation induced cytidine deaminase | 0.463 | 0.885 | 9.2E-06 |
|
group | 0.100 | None | 1.000 | 2 | 0 | 2003 | 2018 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
group | 0.100 | None | 0.933 | 2 | 0 | 2005 | 2019 | ||||||||
|
alanyl aminopeptidase, membrane | 0.462 | 0.769 | 3.7E-09 |
|
group | 0.030 | None | 1.000 | 1 | 0 | 2000 | 2010 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
group | 0.100 | None | 0.976 | 8 | 0 | 1994 | 2019 | ||||||||
|
apoptotic peptidase activating factor 1 | 0.525 | 0.769 | 9.6E-06 |
|
group | 0.030 | None | 1.000 | 1 | 0 | 1999 | 2016 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
group | 0.030 | None | 0.667 | 1 | 0 | 2007 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
group | 0.100 | None | 0.956 | 1 | 0 | 1989 | 2019 | ||||||||
|
aurora kinase A | 0.475 | 0.731 | 0.87 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
B cell linker | 0.603 | 0.731 | 0.61 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2005 | 2006 | ||||||||
|
baculoviral IAP repeat containing 3 | 0.491 | 0.769 | 6.6E-02 |
|
group | 0.100 | None | 1.000 | 1 | 0 | 1999 | 2006 | ||||||||
|
baculoviral IAP repeat containing 5 | 0.495 | 0.731 | 5.6E-02 |
|
group | 0.030 | None | 1.000 | 1 | 0 | 2000 | 2006 | ||||||||
|
BCL10 immune signaling adaptor | 0.491 | 0.769 | 0.34 |
|
group | 0.200 | None | 0.952 | 3 | 0 | 1998 | 2012 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.500 | None | 0.981 | 10 | 0 | 1987 | 2020 | ||||||||
|
BCL2 binding component 3 | 0.517 | 0.769 | 4.0E-03 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2016 | ||||||||
|
BCL3 transcription coactivator | 0.541 | 0.731 | 0.99 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 1993 | 2005 | ||||||||
|
BCL6 transcription repressor | 0.444 | 0.808 | 0.96 |
|
group | 0.200 | None | 0.983 | 8 | 0 | 1993 | 2020 | ||||||||
|
bone morphogenetic protein 6 | 0.531 | 0.808 | 0.76 |
|
group | 0.030 | None | 1.000 | 1 | 0 | 2007 | 2008 | ||||||||
|
bromodomain containing 2 | 0.450 | 0.808 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
BUB1 mitotic checkpoint serine/threonine kinase | 0.528 | 0.731 | 4.9E-09 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
C-C motif chemokine receptor 4 | 0.510 | 0.731 | 6.9E-02 |
|
group | 0.030 | None | 1.000 | 1 | 0 | 2004 | 2019 | ||||||||
|
C-C motif chemokine receptor 6 | 0.485 | 0.808 | 5.8E-03 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2002 | 2018 | ||||||||
|
C-X-C motif chemokine ligand 11 | 0.519 | 0.808 | 0.31 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
group | 0.060 | None | 1.000 | 1 | 0 | 2000 | 2018 | ||||||||
|
C-X-C motif chemokine ligand 13 | 0.472 | 0.731 | 0.83 |
|
group | 0.040 | None | 1.000 | 1 | 0 | 2003 | 2017 | ||||||||
|
C-X3-C motif chemokine receptor 1 | 0.457 | 0.885 | 6.1E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 |